🟢 Pyxis Oncology is trading 5% up today following a $50M private placement and positive analyst commentary

Pyxis Oncology is trading approximately 5% higher at $3.19 as the stock stabilizes following the announcement of a $50 million private placement.

• The financing deal includes attached warrants that could provide additional capital, significantly extending the company's funding runway.
• Shares are gaining momentum from updated analyst commentary regarding the deal and a broader rally across the biotech sector and U.S. equity markets.
• Today's price action reflects improving investor sentiment as the company secures its balance sheet through the new capital raise.